Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
START Madrid is a premier clinical research organization and site network dedicated to conducting Phase I clinical trials for novel anticancer agents. Established in 2009 as the first European site of The START Center for Cancer Research, it operates multiple specialized units in Madrid, including locations at HM CIOCC and Fundación Jiménez Díaz. The center provides a comprehensive range of services for early-phase drug development, including first-in-human studies, pharmacokinetic analysis, and regulatory management. START Madrid is a key partner for global pharmaceutical and biotechnology companies, contributing to the clinical development of numerous oncology therapies that have achieved regulatory approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on START Madrid.